Features
Pricing
Newsletter
Events
Partners
Features
Pricing
Newsletter
Events
Partners
Loading organizations...
abrdn: Funding, Team & Investors | Startup Intros
Home
/
Organizations
/
abrdn
abrdn
Active
Website
LinkedIn
Follow
Copy .md
Share
Post on X
Post on LinkedIn
Share on Reddit
Share on WhatsApp
Share on Telegram
Send an Email
Updated:
Apr 1, 2026
·
Suggest an edit
About
News
Financials
Team
Deep Dive
FAQs
Financial History
Total Raised
N/A
Valuation
N/A
Financial History
Total Raised
N/A
Valuation
N/A
Investments Made
Date
Company
Round
Lead Investor(s)
Co-Investor(s)
Feb 4, 2026
Third Arc Bio
Third Arc Bio Series A Extension
Andreessen Horowitz
, Jorge Conde
, Jorge Conde
AbbVie Ventures
, BVF Partners
,
Freepoint Capital Group
,
Galapagos
,
Hillhouse Capital Group
,
Marshall Wace
,
Omega Funds
, T. Rowe Price Associates
Oct 16, 2025
Veradermics
$150.0M Series C
Katarina Pance
Infinitium
,
Invus
,
LifeSci Venture Partners
,
Longitude Capital
,
Marshall Wace
, Surveyor Capital
,
Suvretta Capital Management
,
Viking Global Investors
Sep 30, 2025
Crystalys Therapeutics
$205.0M Series A
Ashwin Ram
, Novo Holdings
,
SR One
Alexandria Venture Investments
, AN Ventures
,
KB Investment
,
Lightstone Ventures
,
Longwood Fund
, Perceptive Xontogeny Venture Fund
, Pontifax
,
Prebys Ventures Fund
, Wedbush Healthcare Partners
Jul 1, 2024
Third Arc Bio
$170.0M Series A
Vida Ventures
,
Cormorant Asset Management
,
Hillhouse Capital Group
Sofinnova Investments
, AbbVie Ventures
, BVF Partners
,
Foresite Capital
,
Freepoint Capital Group
, Goldman Sachs
, Janus Henderson Investors
,
Logos Capital
,
Marshall Wace
, Francesco Draetta
, Loretta Tse
, T. Rowe Price Associates
Apr 1, 2024
Qlaris Bio
$24.0M Series B
Wende Hutton
,
New Leaf Venture Partners
Adjuvant Capital
,
Canaan Partners
,
Correlation Ventures
,
Mayo Clinic
Apr 1, 2024
Endeavor BioMedicines
$130.0M Series C
AyurMaya
, Karan Takhar
Atlas Venture
,
Hatteras Venture Partners
,
Omega Funds
,
RA Capital
,
Roche Venture Fund
, Ally Bridge Group
,
Avidity Partners
,
Eckuity Capital
, Fidelity Management & Research Company
,
Invus
,
Longitude Capital
,
Perceptive Advisors
, Piper Heartland Healthcare Capital
,
Silver Arch Bio
, SymBiosis
, T. Rowe Price Associates
,
Velosity Capital
,
Woodline Partners
Mar 1, 2024
Engrail Therapeutics
$160.0M Series B
Forbion
, Stacie Weninger
, Tiba Aynechi
Abingworth
,
ARCH Venture Partners
,
F-Prime Capital Partners
,
Jazz Venture Partners
,
Mubadala
, Ed Mathers
,
Novartis Venture Fund
,
Pfizer Venture Investments
,
Pivotal bioVenture Partners
,
Pontifax Venture Capital
,
Red Tree Venture Capital
,
RiverVest
,
Eight Roads Ventures
,
Longwood Fund
, Peter Bisgaard
, Niall O'Donnell
, Guillem Laporta, CFA
Nov 9, 2022
Archax
$28.5M Series A
Russell Barlow
BitRock Capital
, Blockchain Coinvestors
,
CE Innovation Capital
,
Keiretsu Capital
,
Lingfeng Capital
,
Mathrix
, SGH Capital
,
Tezos Foundation
Jan 31, 2022
Dott
$70.0M Series B Extension
Alistair Watson
EQT Ventures
,
Prosus Ventures
, Harold Boël
Dec 1, 2021
Signal AI
$50.0M Series D
Tony Zappala
Celesta
,
LiveOak Venture Partners
,
Redline Capital
, Guardian Media Group Ventures
, Hearst
,
MMC Ventures
,
Redline
Jan 15, 2019
Singlife
$33.0M Other Equity
Hugh Young
,
Aflac Ventures
—